{
    "Trade/Device Name(s)": [
        "FORA G31a/TD-4256A Blood glucose monitoring system",
        "FORA G31b/TD-4256B Blood Glucose Monitoring System",
        "FORA G31 Blood Glucose Meter",
        "TD-4256 Blood Glucose Test Strips",
        "FORA Control Solutions",
        "Taidoc Control Solutions"
    ],
    "Submitter Information": "TaiDoc Technology Corporation",
    "510(k) Number": "K094005",
    "Predicate Device Reference 510(k) Number(s)": [
        "K090187"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NBW",
        "CGA"
    ],
    "Summary Letter Date": "February 04, 2010",
    "Summary Letter Received Date": "March 01, 2010",
    "Submission Date": "December 23, 2009",
    "Regulation Number(s)": [
        "21CFR862.1345"
    ],
    "Regulation Name(s)": [
        "Glucose test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Fresh capillary whole blood",
        "Control solution"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "FORA G31a/TD-4256A meter",
        "FORA G31b/TD-4256B meter"
    ],
    "Method(s)/Technology(ies)": [
        "Electrochemical method",
        "Dry reagent biosensor"
    ],
    "Methodologies": [
        "Quantitative measurement"
    ],
    "Submission Type(s)": [
        "Analyzer",
        "Test Strips",
        "Control"
    ],
    "Document Summary": "FDA 510(k) summary for FORA G31a/TD-4256A and G31b/TD-4256B blood glucose monitoring systems with electrochemical measurement technology",
    "Indications for Use Summary": "Quantitative measurement of glucose in fresh capillary whole blood from finger or specified alternative sites for diabetes monitoring at home or clinical use; not for diagnosis or neonatal use",
    "fda_folder": "Clinical Chemistry"
}